Objective To evaluate the efficacy, safety, stability and predictability of the AcrySof®CACHETTM phakic intraocular lens (PIOL) for the correction of high myopia. Methods In this prospective study, 12 patients (22 eyes) who ranged in age from 19 to 40 with high myopia at -17.25~-6.50 (-11.97±3.03) diopters (D) were implanted with angle-supported phakic intraocular lenses from 2012 January to 2013 February. Visual acuity, refraction, intraocular pressure, corneal endothelium, PIOL position, contrast sensitivity, glare sensitivity, surgical complications and poor visual symptoms were assessed preoperatively and 1 day, 1 month, 3 months, 6 months and 1 year after treatment. The repeated measures ANOVA was used for statistical analysis. Results The mean manifest refraction at the one-year follow-up was within 1D of the attempted correction in 22/22 eyes and 20/22 eyes were within 0.5 D of the attempted correction. At 1 day, 1 month, 3 months, 6 months and 1 year postoperatively, the mean safety indexes were 1.31, 1.36, 1.34, 1.41, 1.31 and the mean efficacy index was 1.23, 1.28, 1.22, 1.23, 1.31. The differences in near vision and intraocular pressure were not statistically significant at any time point. The mean loss of corneal endothelium was 1.69%±2.2%, 2.25%±3.15%, 4.32%±3.04%, 4.27%±3.52%, 3.82%±2.15% at 1 day, 1 month, 3 months, 6 months and 1 year postoperatively. The distance from the central and peripheral corneal epithelium to the AcrySof®CACHETTM phakic IOL was 1.96±0.25 mm (>1.5 mm) and 1.36±0.22 mm (>1.0 mm), and was 0.99±0.08 mm (>0.8 mm) and 0.94±0.09 (>0.8 mm) from the AcrySof®CACHETTM phakic IOL to the natural lens. An analysis of the results of the steadiness of the PIOL showed that it was stable in 11/22 but 6/22 had a clockwise rotation and 5/22 had a counter-clockwise rotation. Improvements were statistically significant when contrast sensitivity and glare sensitivity were compared preoperatively and postoperatively. The study showed that there was a high degree of satisfaction among patients. Conclusion AcrySof®CACHETTM phakic IOL implantation for the correction of high myopia is effective, safe and predictable. It can be a supplement to corneal refractive surgery but follow-up is still required to evaluate the long-term results.
曹伟芳,张素华,赵炬伟,等. 有晶状体眼CACHET人工晶状体植入术治疗高度近视. 中华眼视光学与视觉科学杂志, 2016, 18(4):237-242. DOI:DOI:10.3760/cma.j.issn.1674-845X.2016.04.009.
Cao Weifang,Zhang Suhua,Zhao Juwei,et al. Clinical study of the CACHET phakic intraocular lens for the correction of high myopia. Chinese Journal of Optometry Ophthalmology and Visual science, 2016, 18(4):237-242.
Fechner PU, Strobel J, Wichmann W. Correction of myopia by implantation of a concave worst-iris claw lens into phakic eyes[J]. Refract Corneal Surg,1991,7(4):286-298.
[2]
Stulting RD, John ME, Maloney RK, et al. Three-year results of Artisan/Verisyse phakic intraocular lens implantation. Results of the United States Food And Drug Administration clinical trial[J]. Ophthalmology,2008,115(3):464-472. e1. DOI:http://dx.doi.org/10.1016/j.ophtha.2007.08.039.
[3]
Menezo JL, Cisneros AL, Rodriguez-Salvador V. Endothelial study of iris-claw phakic lens: four year follow-up[J]. J Cataract Refract Surg,1998,24(8):1039-1049. DOI:10.1021/bc010067r.
[4]
Ioannidis A, Nartey I, Little BC. Traumatic dislocation and successful re-enclavation of an Artisan phakic IOL with analysis of the endothelium[J]. J Refract Surg,2006,22(1):102-103.
[5]
Allemann N, Chamon W, Tanaka HM, et al. Myopic angle-supported intraocular lenses:two-year follow-up[J]. Ophthalmology,2000,107(8):1549-1554. DOI:10.1016/S0161-6420(00)00221-9.
[6]
Kohnen T, Klaproth OK. Three-year stability of an angle-supported foldable hydrophobic acrylic phakic intraocular lens evaluated by Scheimpflug photography[J]. J Cataract Refract Surg,2010,36(7):1120-1126. DOI:10.1016/j.jcrs.2010.01.023.
[7]
Bourne WM. Biology of the corneal endothelium in health and disease[J]. Eye (Lond),2003,17(8):912-918. DOI:10.1038/sj.eye.6700559.
Pechméja J, Guinguet J, Colin J, et al. Severe endothelial cell loss with anterior chamber phakic intraocular lenses[J]. J Cataract Refract Surg,2012,38(7):1288-1292. DOI:10.1016/j.jcrs.2012.04.022.
[11]
Ostovic M, Hofmann C, Klaproth OK, et al. Corneal decompensation and angle-closure glaucoma after upside-down implantation of an angle-supported anterior chamber phakic intraocular lens[J]. J Cataract Refract Surg,2013,39(5):806-809. DOI:10.1016/j.jcrs.2013.02.005.
[12]
Alió JL, Pi?觡ero DP, Sala E, et al. Intraocular stability of an angle-supported phakic intraocular lens with changes in pupil diameter[J]. J Cataract Refract Surg,2010,36(9):1517-1522. DOI: 10.1016/j.jcrs.2010.02.028.
[13]
Kermani O, Oberheide U, Gerten G. Rotation stability of the cachet angle-supported phakic intraocular lens[J]. J Refract Surg,2013,29(6):390-394. DOI:10.3928/1081597X-20130515-03.